Insights On Outsourced Drug Development

31. Assessing Viability And Real-Time Apoptosis/Necrosis 3/17/2025

    Malignant gliomas are aggressive brain tumors that resist standard treatments. Discover why researchers focus on real-time cell death dynamics to develop targeted therapies and promising strategies.

32. Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights 3/5/2025

    Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

33. Evolving Gene Editing For Rare Disease Drug Development 10/9/2025

    Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.

34. Simplify Cell Line Development 10/1/2025

    Explore a streamlined method for isolating viable single cells using microfluidic dispensing and whole-well imaging that is designed to improve clonality, cell health, and reproducibility.

35. Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1 12/10/2024

    Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.

36. Breaking The Chains Of Conventional Drug Research Models 8/7/2024

    Gain insight into the limitations of conventional research models, how Organ-Chips are helping researchers bridge the translation gap and overcome pervasive barriers in drug development, and more.

37. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).

38. Explore The Emulate Organ-Chip Portfolio 8/2/2024

    Uncover how these state-of-the-art Organ-Chip technologies can elevate your research and provide deeper insights into human physiology and therapeutic responses.

39. Thermofluor Screening For Injectable Protein Formulations 9/15/2025

    The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.

40. Seed Train Intensification Using High Cell Density Cryopreservation 8/11/2025

    Streamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.